Inactive Instrument
LungLife AI, Inc. Stock
Stocks
LLAI
USU5500L1045
Biotechnology & Medical Research
| 1 day | -2.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Pagano
CEO | Chief Executive Officer | 42 | - |
David Anderson
DFI | Director of Finance/CFO | 63 | - |
Michael Donovan
CTO | Chief Tech/Sci/R&D Officer | 72 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sara Barrington
BRD | Director/Board Member | 59 | 2021-07-07 |
David Anderson
BRD | Director/Board Member | 63 | 2021-07-07 |
Paul Pagano
BRD | Director/Board Member | 42 | 2020-05-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/4/24 | Free | Chief Executive Officer | 769,707 | 3.0201% | ||
| 10/4/24 | Free | Chief Financial Officer | 386,703 | 1.5173% | ||
| 8/14/23 | Buy | Chief Executive Officer | 12,123 | 0.0476% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.35% | +18.57% | - | - | 1.7M | |
| +1.31% | -5.73% | +92.06% | +262.11% | 3.88B | |
| +4.11% | +6.68% | +293.61% | +40.16% | 3.75B | |
| +3.34% | +1.33% | +49.05% | +68.09% | 3.49B | |
| +1.29% | -2.67% | +258.12% | +409.76% | 2.53B | |
| -2.35% | -7.22% | -27.25% | -29.70% | 2.21B | |
| +3.11% | +8.23% | +44.15% | - | 1.64B | |
| -2.73% | -0.31% | +25.39% | +45.25% | 1.1B | |
| +1.10% | -17.08% | +211.39% | -28.35% | 1.09B | |
| -3.61% | -9.78% | +17.22% | +62.07% | 642M | |
| Average | +0.32% | -3.51% | +107.08% | +103.67% | 2.26B | |
| Weighted average by Cap. | +1.54% | -2.10% | +126.13% | +130.38% |
Employees
8
